药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Fosphenytoin
The metabolism of Linagliptin can be increased when combined with Fosphenytoin.
Tetracosactide
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Linagliptin.
Tetracosactide
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Linagliptin.
Tetracosactide
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Linagliptin.
Tetracosactide
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Linagliptin.
Lumiracoxib
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Vemurafenib.
Lumiracoxib
Filgotinib
The serum concentration of Vemurafenib can be increased when it is combined with Filgotinib.
Lumiracoxib
Satralizumab
The serum concentration of Vemurafenib can be decreased when it is combined with Satralizumab.
Lumiracoxib
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Abametapir
The serum concentration of Vemurafenib can be increased when it is combined with Abametapir.
Lumiracoxib
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Capmatinib
The serum concentration of Capmatinib can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Ozanimod
Vemurafenib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Lumiracoxib
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Rimegepant
The metabolism of Rimegepant can be increased when combined with Vemurafenib.
Lumiracoxib
Tafamidis
The serum concentration of Vemurafenib can be increased when it is combined with Tafamidis.
Lumiracoxib
Lumateperone
The serum concentration of Lumateperone can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Cenobamate
The serum concentration of Cenobamate can be decreased when it is combined with Vemurafenib.
Lumiracoxib
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Vemurafenib.
Lumiracoxib
Lefamulin
Vemurafenib may increase the QTc-prolonging activities of Lefamulin.